SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-001768
Filing Date
2018-02-09
Accepted
2018-02-09 16:11:50
Documents
60
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ARWR-Q1-20171231 arwr-10q_20171231.htm 10-Q 1203785
2 EX-31.1 arwr-ex311_6.htm EX-31.1 10485
3 EX-31.2 arwr-ex312_9.htm EX-31.2 10930
4 EX-32.1 arwr-ex321_7.htm EX-32.1 6316
5 EX-32.2 arwr-ex322_8.htm EX-32.2 6563
  Complete submission text file 0001564590-18-001768.txt   4437343

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arwr-20171231.xml EX-101.INS 683697
7 XBRL TAXONOMY EXTENSION SCHEMA arwr-20171231.xsd EX-101.SCH 41453
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arwr-20171231_cal.xml EX-101.CAL 48140
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arwr-20171231_def.xml EX-101.DEF 145375
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20171231_lab.xml EX-101.LAB 365662
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20171231_pre.xml EX-101.PRE 284216
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38042 | Film No.: 18591832
SIC: 2834 Pharmaceutical Preparations